COMPANY

Contraline

HQ: Charlottesville, VA source · contraline.com ↗ · Southeast

Location: Charlottesville, VA · source · Oct 15, 2026

Profile checked Oct 10, 2026

Keywords: Male Contraception ADAM System

Funding and NIH signals

SEC Form D raise Raised $55.8M (Form D filed Jun 10, 2026). SEC Form D 0001818752-26-000003 (Jun 10, 2026)
Evidence (1 event)
- Jun 10, 2026 · SEC Form D 0001818752-26-000003
  Name of Issuer: Contraline, Inc.; CIK: 1818752; Address: Charlottesville, VA; Submission type: D; Filing date: 2026-06-10; Industry Group: Biotechnology; Date of First Sale: 2026-05-29; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 115929658; Total Amount Sold: 55804741; Federal exemptions: 06b
NIH award NIH awarded $829K (SBIR Phase II 5R44HD115509-03, continuation, notice Sep 2, 2026). NIH RePORTER 5R44HD115509-03 (Sep 2, 2026)
Evidence (1 event)
- Sep 2, 2026 · NIH RePORTER 5R44HD115509-03
  Organization: CONTRALINE, INC.; City/State: CHARLOTTESVILLE, VA; Project number: 5R44HD115509-03; Activity code: R44; Fiscal year: 2026; Award notice date: 2026-09-02; FY total cost (award amount): 829377; Administering IC: Eunice Kennedy Shriver National Institute of Child Health and Human Development; Project title: Development of ADAM Air: A Non-Hormonal Vas Occlusive Contraceptive Device; Organization type: Domestic For-Profits

Job counts as of Oct 18, 2026. All funding and NIH signals

May 20, 2022 Trial start Not phased (device or behavioral study): A First in Human Study, Evaluating the Safety and Efficacy of ADAM™ 1.0 source ↗

Record	Title	Phase	Status	Start	Primary completion
NCT05134428	A First in Human Study, Evaluating the Safety and Efficacy of ADAM™ 1.0	Not phased (device or behavioral study)	Completed	May 20, 2022	Mar 20, 2024 (actual)

Annual award amounts. Total $2.2M.

Sep 2, 2026 NIH award 5R44HD115509-03 FY2026: $829,377 awarded for that fiscal year; activity R44 (SBIR); PI TROPSHA, YELENA; recipient as written: CONTRALINE, INC., CHARLOTTESVILLE, VA. Development of ADAM Air: A Non-Hormonal V source ↗
Sep 9, 2025 NIH award 4R44HD115509-02 FY2025: $1,077,116 awarded for that fiscal year; activity R44 (SBIR); PI TROPSHA, YELENA; recipient as written: CONTRALINE, INC., CHARLOTTESVILLE, VA. Development of ADAM Air: A Non-Hormonal source ↗
Sep 10, 2024 NIH award 1R44HD115509-01 FY2024: $291,440 awarded for that fiscal year; activity R44 (SBIR); PI TROPSHA, YELENA; recipient as written: CONTRALINE, INC., CHARLOTTESVILLE, VA. Development of ADAM Air: A Non-Hormonal V source ↗